Office hours: Monday - Friday, 9.00 - 17.00 EDT (UTC-04)
Continuing Professional Education/Accreditation
If you registered after the live Virtual CISTM17 Conference, please see how to apply for CME Credits below:
Acknowledgement of Financial Commercial Support
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society of Travel Medicine (ISTM). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this enduring activity for a maximum of 49.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Amedco LLC designates this Live Activity for a maximum of 49.75 ANCC contact hours.
Pharmacists and Pharmacy Technicians (ACPE)
Amedco LLC designates this live activity for a maximum of 49.75 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Objectives - After Attending This Program You Should Be Able To
1. Understand the science behind COVID-19 including transmission and the impact on travel medicine.
2. Understand and discuss health security, public health emergency response and populations on the move, such as migrants.
3. Understand the approach to syndromic presentations in returned travelers such as neurologic, dermatologic, diarrhea, etc.
4. Learn the most common diseases contracted by travelers, including those classified as emerging threats, as well as the best advice regarding preventative measures.
5. Understand travelers with chronic diseases, children, elderly and pregnant travelers, special populations (e.g. migrants, VFRs), and high-risk travelers (e.g. ill and older travelers).
6. Understand advances in new diagnostic tools in bacterial and viral infections.
7. Understand and discuss specific important tropical diseases seen in both migrants and returned travelers such as malaria, schistosomiasis and leishmaniasis among others.
8. Understand and discuss vectorborne illnesses as they relate to travelers.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest and have been resolved (C7 SCS 6.1-?6.2, 6.5)
All individuals in a position to control the content of CE are listed in the agenda and have disclosed they have no relevant financial relationships.
How to Get Your Certificate: